X4 Pharmaceuticals's market cap is currently $85.02M. The company's EPS TTM is $-0.085; its P/E ratio is ―; X4 Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 3.00M	$ 0.00
Gross Profit	$ -2.00M	$ -1.99M	$ -1.89M	$ 3.00M	$ -672.00K
Operating Income	$ -107.52M	$ -87.57M	$ -85.11M	$ -59.87M	$ -51.70M
EBITDA	$ -107.10M	$ -87.57M	$ -85.11M	$ -58.06M	$ -51.70M
Net Income	$ -101.17M	$ -93.87M	$ -88.70M	$ -62.13M	$ -56.60M
Balance Sheet
Cash & Short-Term Investments	$ 114.22M	$ 121.72M	$ 81.79M	$ 78.71M	$ 126.18M
Total Assets	$ 147.26M	$ 155.59M	$ 117.18M	$ 122.87M	$ 160.70M
Total Debt	$ 58.28M	$ 38.42M	$ 39.78M	$ 38.45M	$ 22.91M
Net Debt	$ -40.94M	$ -83.30M	$ -42.00M	$ -40.26M	$ -103.27M
Total Liabilities	$ 96.16M	$ 81.53M	$ 52.76M	$ 50.07M	$ 31.48M
Stockholders' Equity	$ 51.10M	$ 74.05M	$ 64.41M	$ 72.80M	$ 129.22M
Cash Flow
Free Cash Flow	$ -96.57M	$ -77.20M	$ -71.52M	$ -60.18M	$ -48.23M
Operating Cash Flow	$ -96.51M	$ -77.10M	$ -70.91M	$ -58.82M	$ -48.05M
Investing Cash Flow	$ -14.88M	$ -103.00K	$ -615.00K	$ -1.36M	$ 27.23M
Financing Cash Flow	$ 88.52M	$ 117.23M	$ 74.25M	$ 12.39M	$ 140.66M

Currency in USD

X4 Pharmaceuticals Earnings and Revenue History

Income Statement >

X4 Pharmaceuticals Debt to Assets

Balance Sheet >

X4 Pharmaceuticals Cash Flow

Cash Flow >

X4 Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing